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ABSTRACT
Quorum sensing allows bacterial cells to commu-
nicate through the release of soluble signaling
molecules into the surrounding medium. It plays a
pivotal role in controlling bacterial conjugation in
Gram-positive cells, a process that has tremendous
impact on health. Intracellular regulatory proteins of
the RRNPP family are common targets of these sig-
naling molecules. The RRNPP family of gene regu-
lators bind signaling molecules at their C-terminal
domain (CTD), but have highly divergent function-
alities at their N-terminal effector domains (NTD).
This divergence is also reflected in the functional
states of the proteins, and is highly interesting from
an evolutionary perspective. RappLS20 is an RRNPP
encoded on the Bacillus subtilis plasmid pLS20. It
relieves the gene repression effectuated by RcopLS20
in the absence of the mature pLS20 signaling pep-
tide Phr*pLS20. We report here an in-depth structural
study of apo and Phr*pLS20-bound states of RappLS20
at various levels of atomic detail. We show that apo-
RappLS20 is dimeric and that Phr*pLS20-bound Rap
forms NTD-mediated tetramers. In addition, we show
that RappLS20 binds RcopLS20 directly in the absence
of Phr*pLS20 and that addition of Phr*pLS20 releases
RcopLS20 from RappLS20. This allows RcopLS20 to bind
the promotor region of crucial conjugation genes
blocking their expression.
INTRODUCTION
Quorum sensing in bacterial cells is a process that allows
bacterial cells to exchange information about their state and
content (1). The external signals are used by cells to change
the expression profile of their genes thereby affecting many
processes that are candidates for interference in some way,
including the control of expression of virulence factors and
the control of bacterial conjugation. In Gram-positive bac-
teria, the mechanism of action of the signaling molecules
is either through activation of a kinase-dependent signaling
cascade (the two-component pathway), or by direct interac-
tion with a transcriptional regulator.
The RRNPP family of Gram-positive tetratricopeptide
repeat (TPR) proteins (2,3) was so named after discovery
of the main representatives of the family, i.e. the proteins
Rgg, Rap, NprR, PrgX and PlcR (4–7). In Gram-positive
bacteria, RRNPP proteins play a crucial role in quorum
sensing (8,9), where they serve as targets of their cognate
signaling polypeptide. This peptide is produced, secreted,
processed and then reimported into the bacterial cells that
also produce the RRNPP. The mature, processed signal-
ing peptide generally consists of a small fragment of the C-
terminus of the full-length pre-proprotein, generally about
5–10 amino acids in length (10). Binding of the processed
peptide to the C-terminal TPR domain of RRNPP pro-
teins modulates interaction between the RRNPP protein
and an effector molecule, leading to further downstream ef-
fects. Interaction with effector molecules depends on the N-
terminal domain (NTD; effector domain) of the RRNPP
(6,11). Thus, the nature of the effector molecule and there-
fore the function of the RRNPP proteins depend on the type
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of effector domain incorporated at the N-terminus. The
RRNPP-mediated quorum sensing mechanism is involved
in the regulation of a variety of bacterial processes in-
cluding conjugation (e.g. PrgX from the enterococcal plas-
mid pCF10), sporulation (e.g. RapA from Bacillus subtilis)
and pathogenicity (e.g. PlcR from B. cereus) (7,12), and is
found in a range of human commensal or pathogenic Gram-
positive bacterial genera such as Bacillus, Streptococcus and
Enterococcus (13). Interestingly, RRNPP-like proteins have
been found beyond the realm of Gram-positive bacterial
genomes, as illustrated by the recent structure determina-
tion of a regulator of phage lysis-lysogeny, AimR (14), or
in the NlpI protein from Gram-negative Escherichia coli,
which contains a lipobox motif that anchors it to the mem-
brane (15).
The effector domains of RRNPP proteins known to date
can be classified into three groups. The effector domains
of the DNA-binding RNPP subclass of proteins are helix-
turn-helix (HTH) motifs that are able to negatively regu-
late protein expression by binding DNA, examples of which
are the PrgX protein from Enterococcus faecalis and the
PlcR protein from Bacillus thuringiensis. A second group
of proteins, exemplified by B. subtilis RapA, RapB, RapE,
RapH and RapJ, contains an NTD with phosphatase ac-
tivity. These proteins form a link in a phosphorylation cas-
cade that translates the peptide signal into a downstream
effect. The third group, which includes RapC, RapF, RapG,
RapH and RapK, blocks the action of their cognate ef-
fector protein by direct interaction, directly or indirectly
modulating expression that alters differentiation pathways.
Note that RapH belongs to both least two groups as it ex-
hibits both activities. Similarly, NprR contains both a phos-
phatase and a HTH domain. The variety in functions of
different types of RRNPP proteins is also reflected in the
differences in oligomerization state and the effect that the
peptide can have on oligomerization. Different Rap pro-
teins, even within a single functional class, have been found
as monomers, dimers and tetramers, and these oligomeriza-
tion states may change or remain the same depending on
the presence of the peptide. For example, RapJ and RapF
are found as monomers (16,17), whereas RapH is reported
to be a dimer in solution (18). It seems that the aggregation
behavior of RRNPP proteins does not depend directly on
the functionality of the NTD, and there is no obvious com-
mon theme in how the oligomerization state of the different
RRNPP family members relates to the mechanism (19).
Bacillus subtilis encodes 11 Rap proteins on its chro-
mosome (6,10,20), and at least five plasmid-encoded vari-
ants (21,22). A recently identified B. subtilis RRNPP mem-
ber (22,23), RappLS20, is encoded by the Gram-positive B.
subtilis conjugative plasmid pLS20. It lacks the conserved
residues essential for phosphatase activity and has been
shown to regulate the conjugation process. The conjuga-
tion genes of pLS20 are located in a single large operon
that is under the control of the conjugation promoter Pc. By
default, this promoter is repressed by the pLS20-encoded
transcriptional regulator RcopLS20 (23). RappLS20 activates
conjugation by acting as an antirepressor of RcopLS20 (22),
which induces the formation of a DNA loop by binding
to two closely located recognition sequences near the Pc,
thereby inhibiting expression of the conjugation genes and
plasmid transfer (23). RappLS20 is essential to activate tran-
scription of the conjugation genes by releasing RcopLS20-
mediated Pc repression, which may involve a direct interac-
tion between both. The presence of the Phr*pLS20 peptide
antagonizes the antirepressive action of RappLS20, revert-
ing the system to its default state (22). The pre-proprotein
PhrpLS20 is a 44-amino acid protein, and after secretion, it
is subject to a second processing step resulting in the re-
lease of the C-terminal 5 amino acids (QKGMY), which can
be reimported in an opp-dependent manner (22). The ge-
netic switch constituted by the aforementioned components
is tightly regulated due to its design. However, the structural
basis underlying this mechanism has not been reported.
Here, we demonstrate that RappLS20 can interact directly
with either RcopLS20 or Phr*pLS20. In addition, we have
determined the crystal structures of RappLS20 in the apo
form as well as in the peptide-bound form to understand
the structural mechanism behind peptide-mediated release
of antirepression of RcopLS20 by RappLS20. The structures
are validated by SAXS measurements in solution. Surpris-
ingly, our work reveals a tetrameric oligomerization state
of RappLS20 in the presence of the peptide mediated by the
NTDs, which has not been observed for other Rap pro-
teins. The oligomerization state and structural changes in-
troduced by peptide binding are compared with informa-
tion available for other RRNPP members. We find that the
peptide-induced change in orientation of the NTDs ob-
served for RappLS20 is different to that observed for other
RRNPP proteins. Thus, the position of the NTDs in apo
and peptide-bound forms depends very much on the asso-
ciated functionality. Implications of the structural findings
on the mechanism of action of RappLS20 are discussed.
MATERIALS AND METHODS
Sequence alignments
A set of RappLS20-like protein sequences was retrieved us-
ing an iterative PSI-BLAST search for 11 iterations and
standard parameters. The representation of the sequence
homology was obtained using the HMM-LOGO program
(24).
Protein expression and purification
RappLS20 and RcopLS20 were expressed and purified using
standard protocols. Escherichia coli BL21 (DE3) were trans-
formed with pET-28b carrying the insert of rappLS20 or
rcopLS20 containing a C-terminal His-tag and were inoc-
ulated in fresh Luria-Bertani broth (LB) media comple-
mented with 50 g/ml kanamycin at 37◦C overnight. Then,
the cells from the overnight culture were collected by cen-
trifugation (4000 × g for 30 min) and suspended in expres-
sion media (typically 0.5 l of terrific broth (TB) with 50
g/ml kanamycin), at a ratio of 30 ml of preculture per liter
of medium. Cells in expression media were grown at 37◦C
until an OD600 = 0.8–1 was reached. After that, protein
expression was induced overnight at 20◦C by addition of
1 mM isopropyl -D-1-thiogalactopyranoside (IPTG, Om-
nipur).
After overnight induction, cells were centrifuged at
4000 × g for 30 min, and pellets were frozen and resus-
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pended in lysis buffer at a ratio of 5 ml/g of cells. The ly-
sis buffer used for RappLS20 contained 50 mM Tris–HCl pH
8.0, 250 mM NaCl, 1% (v/v) glycerol, 10 mM MgCl2, 1 mM
EDTA, 1 mM -mercapto-ethanol, 1 mM PMSF, and the
buffer used for RcopLS20 contained 20 mM Tris–HCl pH
8.0, 500 mM NaCl, 1% (v/v) glycerol, 10 mM MgCl2, 1
mM EDTA, 1 mM -mercapto-ethanol, 1 mM PMSF. The
cell suspension was lysed adding DNAseI to a a final con-
centration of 200 g/ml and lysozyme to a final concentra-
tion of 100 g/ml during sonication. Insoluble matter was
precipitated by centrifugation (18 000 × g, 30 min), and
supernatant was filtered through a 0.22-m filter and ap-
plied to a nickel-charged His-Trap™ HP chelating column 5
ml (GE Healthcare Life Sciences). The column was washed
with 10 column volumes of bind buffer (20 mM Tris–HCl
pH 8.0, 500 mM NaCl, 5 mM Imidazole) to elute unspecific
bound proteins. Bound proteins were eluted using a 5–100
mM imidazole gradient in 20 mM Tris–HCl pH 8.0, 500
mM NaCl. Fractions containing protein were concentrated
with an Amicon ultra 10 kDa MWCO (Millipore) and the
buffer was exchanged using a PD-10 desalting column (GE
Healthcare life sciences) to 20 mM Tris–HCl pH 8.0, 250
mM NaCl, 10 mM MgCl2, 1 mM EDTA, 1% (v/v) glycerol
buffer for RappLS20 and to 500 mM NaCl, 20 mM Tris–HCl
pH 8.0 buffer for RcopLS20. Typically, a yield of ∼100 mg of
RappLS20 and ∼20 mg of RcopLS20 were obtained from 10 g
of pellet. Purity was assessed to be >95% by SDS–PAGE,
followed by Coomassie Blue staining. Protein concentration
was determined by nanodrop and was used for assays imme-
diately where possible or stored in aliquots at -80◦C.
Analytical size exclusion chromatography on RappLS20 and
RcopLS20 mixtures
To determine the elution volumes of the separate pro-
teins, 25 g (0.56 nmol) of RappLS20 and 25 g (1.2 nmol)
RcopLS20, respectively, were injected on a Superdex 200 in-
crease 5/150 GL equilibrated with 500 mM NaCl, 20 mM
TRIS pH 8, and eluted at a flow rate of 0.2 ml/min. The
concentrations of RappLS20 and RcopLS20 solutions were 1
mg/ml, or 22.5 M and 49.4 M, respectively. For com-
plex binding stoichiometry tests, molar ratios of 1:2, 1:4,
1:1 and 2:1 (RcopLS20:RappLS20) were prepared and incu-
bated for 30 min on ice before injection. To study the effect
of Phr*pLS20 peptide on RappLS20/RcopLS20 complex forma-
tion, a 5:1 Phr*pLS20:RappLS20 stoichiometry was used; 25
l were injected in all cases. All total protein concentra-
tions were within a 0.75–1.25 mg/ml range. To estimate the
molecular weights (Mw) of the homo- and heterocomplexes,
a calibration of the Superdex 200 increase 5/150 GL column
was performed using proteins with known Mw, which were
eluted using the same elution buffer used above. The derived
relation between the elution volume (Vel) and Mw was Vel
= –0.6815 · log(Mw) + 5.1906, with an R2 = 0.933.
Sedimentation velocity assays (SV)
Samples of protein RappLS20 in 20 mM Tris, 250 mM NaCl,
10 mM MgCl2, 1 mM EDTA, 0.1 mM -mercaptoethanol
and 1% (v/v) glycerol, pH 7.4, were loaded (320 l) into
12-mm Epon-charcoal standard double-sector centerpieces.
The assays were performed at 48 000 rpm in an XL-I analyt-
ical ultracentrifuge (Beckman-Coulter Inc.) equipped with
both UV–VIS absorbance and Raleigh interference detec-
tion systems, using an An-50Ti rotor. Sedimentation pro-
files were recorded simultaneously by Raleigh interference
and absorbance at 280 nm. Differential sedimentation coef-
ficient distributions were calculated by least-squares bound-
ary modelling of sedimentation velocity data using the con-
tinuous distribution c(s) Lamm equation model as imple-
mented by SEDFIT (25). These experimental s values were
corrected to standard conditions using the program SED-
NTERP (26) to get the corresponding standard s values
(s20,w). For apo RappLS20, measurements were performed
at 4.5 and 25 M (0.2–1.1 mg/ml). For the Rap-Phr com-
plex, a RappLS20 concentration of 4.5 M (0.2 mg/ml) was
used.
Sedimentation equilibrium assays (SE)
Short column (95 l) SE experiments of RappLS20 were car-
ried out at speeds ranging from 7000 to 10 000 rpm and
at 280 nm, using the same experimental conditions and
instrument as in the SV experiments. A last high-speed
run (48 000 rpm) was done to deplete protein from the
meniscus region to obtain the corresponding baseline off-
sets. Weight-average buoyant Mw of RappLS20, alone or in
the presence of the Phr*pLS20 peptide, were obtained by
fitting a single-species model to the experimental data us-
ing the HeteroAnalysis program (27), once corrected for
temperature and solvent composition with the program
SEDNTERP (26).
Fluorescence polarization binding assays
Binding of the Phr*pLS20 peptide was assayed in a CLAR-
IOstar plate reader (BMG Labtech) on an OptiPlate-384
Black well plate (PerkinElmer) in 10 l final assay volume.
The Phr*pLS20 peptide (GQKGMY, the glycine residue was
added at the N-terminus to avoid interference with the dye)
used for fluorescence polarization measurements was syn-
thesized with an N-terminal fluorescein label and purified
by ThermoFischer Scientific. The buffer used for the fluo-
rescence polarization assays was 20 mM Tris pH 7.5, 150
mM NaCl, 1 mM DTT and 0.01% (v/v) Triton X-100. All
buffers were properly degassed under vacuum and oxygen
was removed saturating with nitrogen to prevent methion-
ine oxidation. The protein concentration was varied from
0.1–100 M and the peptide concentration was 50 nM. An
excitation wavelength of 485 nm and an emission wave-
length of 528 nm were used. For equilibrium competition
binding assays, different concentrations of native Phr*pLS20
(QKGMY) ranging from 0.6–1250 M were tested, with
constant concentrations of RappLS20 (10 M) and 6-FAM-
Phr*pLS20 (50 nM). The data was measured at 25◦C and cor-
rected for background by subtracting the free-labeled pep-
tide background. All the data treatment was done as previ-
ously described (28) and the data was fitted to a hyperbolic
function for a single binding site using Origin 2018 (Origin-
Lab Corporation).
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SAXS analysis
Different concentrations of RappLS20, ranging from 0.5 to 5
mg/ml (11.3–113 M), and RcopLS20, ranging from 1.44 to
14.4 mg/ml for RcopLS20 (70.9–709 M), were tested to en-
sure proper scattering and signal detection. In the case of
RappLS20/Phr*pLS20 samples, the same concentrations were
tested in the presence of 5-fold peptide molar concentra-
tion. All the samples were prepared in a final buffer con-
sisting of 15 mM HEPES pH 7.5, 150 mM NaCl, 1 mM
DTT. SAXS data on RappLS20 and Phr*pLS20 mixtures were
collected at NCD-SWEET beamline (BL11, ALBA Syn-
chrotron, Barcelona). The final buffer was collected for sub-
traction of RappLS20 samples, and the buffer plus the highest
Phr*pLS20 concentration was also collected to ensure that no
observable scattering was produced by the Phr*pLS20 pep-
tide. Measurements were carried out at 293 K in a quartz
capillary of 1.5 mm diameter and 0.01 mm wall thickness.
The data (20 frames with an exposure time of 0.5 sec/frame)
were recorded using a Pilatus 1M detector (Dectris, Switzer-
land) at a sample-detector distance of 2.56 m and a wave-
length λ = 1.0 Å.
Data on mixtures of RappLS20, RcopLS20 and Phr*pLS20
were measured on beamline BM29 at the ESRF, using the
automatic sample changer. The concentration ranged from
0.5 to 5 mg/ml (11.3–113 M) for Rap and 1.44 to 14.4
mg/ml for Rco (70.9–709 M). Ten consecutive frames
were collected with a photon-counting Pilatus 1M detec-
tor at a sample-detector distance of 2.85 m, a wavelength
λ = 0.991 Å and an exposure time of 1 s/frame. A mo-
mentum transfer range of 0.036–0.50 Å−1 was covered (q =
4sin θ/λ, θ being the scattering angle and λ the wavelength
of the incident X-ray beam). Data collected during continu-
ous sample flow through the capillary were subtracted from
buffer scattering. The frames showing a negligible variation
of the radius of gyration (Rg) were merged for further anal-
ysis.
R g values were obtained from the Guinier approximation
sRg <1.3 using Primus (29). Distance distribution functions
p(r) and the Porod volumes (Vρ) were computed from the
entire scattering curve using GNOM (30). Buffer subtrac-
tion and extrapolation to infinite dilution were performed
by using the program package Primus (30) from the AT-
SAS 2.8.4 software suite. The forward scattering (I(0)) and
the radius of gyration (Rg) were evaluated by using the
Guinier approximation, and the maximum distance Dmax
of the particle was also computed from the entire scatter-
ing patterns with GNOM. The scattering from the crystal-
lographic models was computed with CRYSOL (31). The
volume fractions of the oligomers were determined with
OLIGOMER (32), using as probe a set of two structural
models corresponding to the monomer and the dimer, and
a set of two PDBs corresponding to the dimer and the
tetramer. The monomer, dimer and tetramer models were
derived from structures presented herein.
Protein crystallization
Purified RappLS20 was concentrated to 10 mg/ml in 20 mM
Tris–HCl pH 8, 250 mM NaCl, 10 mM MgCl2, 1 mM
EDTA, 1% (v/v) glycerol. Crystals of RappLS20 giving the
highest resolution were obtained by the sitting-drop vapor-
diffusion method at 18◦C, by equilibration of drops of 1 l
protein + 1 l crystallization buffer (10% (w/v) PEG6K, 0.1
M Hepes pH 7, benzamidine hydrochloride 0.1 M) against
100 l of the crystallization buffer. Needle-shaped crystals
were cryo-cooled in liquid nitrogen using a cryo-protecting
solution containing reservoir solution supplemented with
20% (v/v) glycerol.
For crystallization experiments of the
RappLS20/Phr*pLS20 complex, the peptide was added
to the diluted protein at a ratio of 1:5 (RappLS20/Phr*pLS20)
and the mixture was concentrated to 10 mg/ml in 20 mM
Tris–HCl pH 8, 250 mM NaCl, 10 mM MgCl2, 1 mM
EDTA, 1% (v/v) glycerol. Crystals of RapLS20- Phr*pLS20
were obtained by sitting-drop vapor-diffusion at 18◦C, by
equilibration of drops of 1 l protein + 1 l crystallization
buffer (2.5% (w/v) PEG8K, 8% (v/v) ethylene glycol, 0.1
M MES pH 6.8) against 100 l of the crystallization buffer.
Data collection was performed at ALBA synchrotron
Light Source on the BL13-Xaloc beamline (33). The crys-
tals of native RappLS20 belonged to space group P21212 with
two protein molecules in the asymmetric unit. The crys-
tals of the RappLS20/Phr*pLS20 complex belonged to space
group C2, with four protein molecules in the asymmetric
unit. Data were processed with AutoPROC (Global Phasing
Ltd, (34)), using anisotropic resolution cutoffs (35). Data
processing statistics are presented in Table 1.
Structure refinement
The TPR domain of the structure of the RapF protein
with PDB code 4I9E (11) was used for molecular replace-
ment by the program phaser (36). The native model of
RappLS20 was then used for molecular replacement for the
RappLS20/Phr*pLS20 data. Crystallographic refinement of
the models was done using phenix 1.12–2829 (37) and man-
ual building in Coot (38), using the 2Fo − Fc and Fo − Fc
electron-density maps from refinement. Refinement statis-
tics are presented in Table 1. Figures were prepared using
PyMOL (The PyMOL Molecular Graphics System, Ver-
sion 1.8 Schrödinger, LLC). Sequence and secondary struc-
ture were visualized using ESPript (39). The apo structure
of RappLS20 was deposited as PDB code 6T3H and the
peptide-bound structure was deposited as PDB code 6T46.
Superposition of RappLS20 monomers
To quantify changes in conformation between different,
yet equivalent structures, the displacements of the equiva-
lent atoms were expressed as a root-mean-square deviation
(RMSD) of the atomic positions after superpositioning dif-
ferent parts of the structures. The main chain atoms of ei-
ther the matching full length sequence (residues 9–361), or
of residues 80-361 (CTD), or of residues 9–68 (NTD), re-
spectively, of each of the crystallographically independent
monomers of the RappLS20 apo and RappLS20/Phr*pLS20
structures were superposed using the least squares algo-
rithm implemented in Coot. The superposition of the main
chain atoms of residues 268–361, corresponding to residues
in H13-H17, was calculated using the fit command in Py-
mol. The rms cur command in Pymol was used to calculate
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Table 1. X-ray data processing and refinement statistics
Data processing statistics Rap apo (6T3H) Rap+Phr* (6T47)
Space group P 21 21 2 C 1 2 1
Unit-cell parameters (Å) a = 111.790, b = 174.487, c = 49.879 a = 116.67, b = 93.28, c = 167.69
Unit-cell angles (◦)  =  =  = 90  =  = 90,  = 94.97
Resolution range (Å)a 87.2–3.04 (3.09–3.04) 45.4–2.450 (2.492–2.450)
No. of unique reflections 18645 (797) 63446 (3200)
Spherical completeness (%) 95.3 (82.5) 96.1 (96.8)
Ellipsoidal completeness (%) 95.3 (82.5) 95.9 (95.6)
Redundancy 4.6 (4.5) 2.2 (2.2)
Mean I/(I) 14.8 (1.4) 10 (0.3)
Rmeas (%)b 7.5 (104.1) 4.4 (154.7)
Refinement statistics
Rworkc (%) 20.13 19.93
Rfreed (%) 25.93 25.68
Ramachandran
Favored (%) 92.95 96.4
Disallowed (%) 1.13 1.31
R.M.S.D.
Bond lengths (Å) 0.004 0.01
Bond angles (◦) 0.734 1.503
Chirality
Mean B value (Å2) 95.4 73.3
aNumbers in parentheses represent values in the highest resolution shell.
bRmeas =
∑
hkl [N/N – 1]1/2
∑




iIi(hkl) where N is the multiplicity of a given reflection, Ii(hkl) is the integrated intensity of a
given reflection and <I(hkl)> is the mean intensity of multiple corresponding symmetry-related reflections.
cRwork =
∑
||Fobs | – |Fcalc ||/
∑
|Fobs |, where |Fobs | and |Fcalc | are the observed and calculated structure factor amplitudes, respectively.
dRfree is the same as Rwork but calculated with a 5% subset of all reflections that was never used in refinement.
the RMSD of the main chain atoms of residues 9–68 after
superposition of residues 80–361.
RESULTS
This study shows that the oligomerization state of RappLS20
is concentration dependent. For the purpose of compari-
son, Supplementary Table S1 lists the concentrations used
for the solution experiments.
Overall structure of RappLS20
The apo structure shows that RappLS20 is all -helical,
consisting of 17 antiparallel helices that are connected by
short loops (Figure 1A and B). The C-terminal region con-
sists of 14 helices forming 7 bi-helical TPR motifs, mak-
ing up the typical solenoid structure associated with TPR
folds (2). The solenoid covers more than a full turn, result-
ing in an interaction of the C-terminus with H5 and H6.
The channel of the solenoid structure is open towards the
N-terminus, but tightens towards the C-terminus, mainly
due to the presence of the sidechains of residues R261
and W225.
The inner surface of the solenoid is lined by the even-
numbered helices from H4 to H16 (Figure 1B), which form
the pocket to which the peptide binds. The TPR topology is
lost at the N-terminal end of helix H4, as helix H3 is located
towards the inner lining and helix H2 towards the outer lin-
ing of the solenoid, an inversion with respect to helices H4
and H5. The loop between helices H3 and H4, indicated
in red in Figure 1B, therefore marks the boundary between
the NTD and the C-terminal TPR domain. This loop is the
longest loop in the structure, consisting of 13 residues, and
shows up poorly in the electron density maps, indicating a
high degree of flexibility. Helices 1–3 form an antiparallel
three-helix bundle, where helices H1 and H3 interact with
the N-terminal region of helix H4. Helix H2 packs with he-
lix H1 and the opposing side of helix H3 is exposed to the
exterior part of the protein.
The three helices of the NTD are approximately parallel
and therefore do not form a HTH topology. Instead, their
configuration resembles that of the TPR fold, but the do-
main is tilted with respect to the C-terminal TPR domain.
The linker between helices 3 and 4 mentioned above pro-
vides the flexibility required for this change in orientation.
This implies flexibility of the functionally important NTD
domain, which relays peptide binding to a downstream re-
sponse (6).
RappLS20 forms dimers in the packing of the crystal struc-
ture in a similar fashion to the B. subtilis phosphatase RapH
(18). The interaction involves the protein surface of helices
H5–H7 and H16–H17, including the C-terminal residues
(Figure 1B and C). The N-terminal entrances of the chan-
nels of the solenoid structures face outwards with respect to
the dimer interface. The buried solvent-accessible surface of
the dimer interface in the apo structure is presented in Ta-
ble 2. It is the largest buried surface area in the structure,
and corresponds to the interface having the strongest inter-
actions present in the structures according to strength indi-
cators (see Table 2).
RappLS20 oligomerization state in solution
To determine whether the apo form of RappLS20 also forms
dimers in solution as observed in the crystal structure, we
carried out two complementary analytical ultracentrifuga-
tion (AU) approaches: sedimentation velocity (SV) and sed-
imentation equilibration (SE) experiments. In SV experi-
























Figure 1. Overall crystallographic structure and ultracentrifuge results of apo RappLS20. (A) Sequence and secondary structure of the apo structure. (B)
N-terminal view of a cartoon representation of the apo RappLS20 structure. Helices H1–H3 of the N-terminal domain are shown in gray, the H3–H4 loop
in red and the even-numbered TPR helices lining the solenoid in yellow. Uneven-numbered helices are shown in green. (C) Cartoon representation of the
side view of the dimeric structure of apo RappLS20 in two orientations. (D) Sedimentation velocity assay showing the sedimentation coefficient distribution
c(s) corresponding to 4.5 M (0.20 mg/ml) purified RappLS20. (E) Sedimentation equilibrium assay. Upper part: concentration gradient of experimental
data for RappLS20 (empty circles) are presented together with best-fit analysis assuming protein monomer (dashed line), dimer (black line), or tetramer
(dotted line) species. Lower part: Difference between experimental data and estimated values for a protein dimer model (residuals).
ments, more than 96% of RappLS20 was observed as a sin-
gle species with an experimental sedimentation coefficient
of 4.9 S at 4.5 M (0.20 mg/ml). This sedimentation co-
efficient, after correction to standard conditions (S20,w =
5.4S), was compatible with the theoretical mass of a slightly
elongated RappLS20 dimer (f/f0 = 1.3) (Figure 1D). Since the
apparent Mw obtained in SV analyses is influenced by the
shape of the protein complex, we also performed SE experi-
ments at concentrations ranging from 4.5 to 25 M or 0.20
to 1.1 mg/ml (Figure 1E). The buoyant mass obtained was
22 930 ± 110 Da, corresponding to a molar mass of 89 970
± 440 Da, using a partial specific volume of 0.7363, con-
firming that RappLS20 (theoretical Mw of 44.4 kDa) behaves
predominantly as a dimer in solution.
Structural comparison and evolutionary link
Given the low sequence homology among members of
the RRNPP family (6), a comparison of the structure of
RappLS20 with other known structures in the PDB database
could be very insightful (40). The full sequence of the apo
structure was subjected to a PDB eFold search (41), sum-
marized in Supplementary Table S2, in which the RRNPP
proteins are grouped according to their function and source
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Table 2. Relevant parameters indicating the strengths of the interface areas between the C-terminal TPR dimerization domains (CTD) and N-terminal
tetramerization domains (NTD), respectively, for the different monomers in the asymmetric units in apo and peptide-bound RappLS20 structures
Structure Interactions Area (Å2) G G/P CSS
Rap Apo CTD of Chain A with chain B 1432 −10.2 0.341 0.79
Rap Pep CTD of Chain A with chain C 1606 −12.2 0.285 0.453
CTD of Chain E with chain G 1440 −13.6 0.205 1.00
Rap Apo tetramer NTDs of Chain A with chain B* 1347 −24.1 0.01 0.85
Rap Pep NTDs of Chain G with chain E* 1207 −16.6 0.05 1.00
NTDs of Chain C with chain A* 1306 −22.1 0.01 0.516
*The interaction is with the indicated chain of a symmetry-related molecule.
organism. The table is complemented with relevant RRNPP
and non-RRNPP entries that were not identified by the
eFold search. The search resulted in the retrieval of most
but not all RRNPP proteins, indicating that there are sig-
nificant structural differences between RappLS20 and some
RRNPP members, particularly in the NTD. Most interest-
ingly, a number of non-related TPR proteins were found to
have a greater structural similarity to RappLS20 than some
of the RRNPP proteins, suggesting that the RRNPP pro-
teins and the non-RRNPP hits stem from a common an-
cestor. When investigating the structural similarities, it be-
came clear that the evolutionary link between these proteins
lies in the peptide binding function of the TPR domain.
For example, human LGN is one of the proteins that were
found to have a TPR domain that is structurally similar to
RRNPP proteins. Human LGN is involved in mitotic spin-
dle orientation of eukaryotic cell division, and in order to
do so, it must be able to interact with different partner pro-
teins (42,43) by binding to a polypeptide segment of each.
However, the peptides to which LGN binds are generally
much longer than the processed signaling molecules in bac-
terial quorum sensing, and RRNPP proteins are unable to
bind long peptides because the peptide binding site at the
C-terminus forms a cul-de-sac in which only short peptides
are able to fit. A second functionally and structurally impor-
tant adaptation between RRNPP and LGN is related to the
NTD, which is absent in LGN.
Fluorescence polarization binding assay
We have determined by fluorescence anisotropy the affinity
of a synthetic Phr*pLS20 peptide to RappLS20 using a com-
petition assay between a chromophore-labelled (6-FAM-
Phr*pLS20) and an unlabeled Phr*pLS20 peptide following
a previously described protocol (44). Briefly, fluorescence
anisotropy was measured for samples containing fixed con-
centrations of RappLS20 and 6-FAM-Phr*pLS20 and increas-
ing concentrations of native Phr*pLS20. The binding data
obtained in these fluorescence polarization assays were fit-
ted (Figure 2A) to the Hill-Langmuir equation (45), result-
ing in a Hill coefficient of 1 (no cooperativity in the inter-
action). The determined IC50 was 26.73 ± 0.27 M, which
corresponds to a KD value of 7.42 M, which is in the same
range as the 3.1 M KD value calculated for the RapF-
PhrF* pair (11), but significantly less than the 0.03 M
calculated for NprR and its cognate peptide NprX (46).
The difference in peptide affinity between Rap proteins and
NprR may be explained by the difference in length of the
peptide (five amino acids for the Phr peptides and eight for
NprX). The KD value allowed us to estimate the proper ratio
of RappLS20/Phr*pLS20 required to obtain high percentage
of protein bound to the peptide. Unless stated otherwise, a
ratio of 1:5 (RappLS20:Phr*pLS20) was chosen for the exper-
iments described herein, as under these conditions a 98.8%
Phr*pLS20 was calculated to be bound to the protein.
Structures of peptide-bound RappLS20
Having resolved the structure of the apo form, we were in-
terested in revealing the structural effects of Phr*pLS20 bind-
ing on RappLS20. Crystals diffracting at 2.45 Å were ob-
tained, and X-ray analyses revealed that the peptide-bound
RappLS20 crystallized in a different space group with distinct
cell parameters (see Table 1), consisting of four indepen-
dent chains in the asymmetric unit. The electron density
of the peptide was clearly observed in all chains (Supple-
mentary Figure S1). The approximate location and orien-
tation of the peptide in the TPR domain of RappLS20 is pre-
served compared with other members of the RRNPP fam-
ily (not shown). The peptide is oriented along the solenoid
axis of the TPR domain, with its N-terminus bound in a
closed pocket pointing towards the C-terminus of RappLS20.
The C-terminus of the peptide, however, points towards an
open channel, which provides clues about how the pep-
tide enters the active site. Interestingly, superpositions with
other RRNPP-peptide structures show that small relative
displacements of the peptide occur along the solenoid di-
rection (not shown). Recognition of the peptide by RappLS20
involves residues from helices H6, H8, H10, H12, H14 and
H16 (Figure 2B).
The sequence of the mature Phr*pLS20 peptide corre-
sponds to the last five amino acids of the pre-proprotein,
residues forty to forty-four, with the sequence QKGMY.
Phr*pLS20 adopts an extended conformation, with residues
Q40 and K41 pointing in opposite directions with respect
to the main chain, as do residues M43 and Y44 (Figure
2B). Thus, residues K41 and Y44 point towards helix H6,
whereas Q40 and M43 point towards the interface between
helices H10 and H12. K41 interacts with residues at the top
of helix H6. This part of H6 interacts in turn with helices
H16 and H17, which are involved in the dimer interface.
The peptides of the four monomers of the peptide-bound
RappLS20 structure were superposed to visualize the move-
ment of RappLS20 structural elements with respect to the
peptide. This analysis shows that in one of the Phr*pLS20-
bound chains, the C-terminal helices H13-H17 of the TPR
moves downwards by 2.6 Å, bringing these helices close to
the helices H5–H7.














H10 H6 H14 
C D 
B 
Figure 2. Interaction of the Phr*pLS20 peptide with RappLS20. (A) RappLS20/Phr*pLS20 binding affinity as determined by fluorescence polarization. The
black-colored data points represent the fluorescence polarization of the 6-FAM-labeled Phr*pLS20 peptide as a function of RappLS20 concentration. The
red-colored data points shows the results of a fluorescence anisotropy competition assay with unlabeled Phr*pLS20. The black and red lines represent the fit
of the experimental data to the Hill equation for a single binding site. Error bars represent standard deviations from four samples. (B) Stick representation
of the crystal structure of the peptide-bound crystallographic structure, showing the carbon atoms of the peptide in orange and those of RappLS20 in green.
Interacting residues of RappLS20 are indicated. (C) Sedimentation coefficient distributions, c(s), obtained from SV assays at 280 nm with 4.5 M of apo
RappLS20, showing the shift in the s-value of this protein after addition of Phr* at 4.5 M (dotted line) or 15 M (dashed trace) relative to RappLS20 alone
(solid trace). (D) Sedimentation equilibrium assay. Upper part: concentration gradient of experimental data for RappLS20 with Phr*pLS20 at 15 M (empty
circles) are presented together with best-fit analysis assuming protein dimer (dashed line), tetramer (black line) or hexamer (dotted line) species. Lower
part: Difference between experimental data and estimated values for the protein tetramer model (residuals).
The superpositions of the peptides revealed a significant
degree of freedom of movement, which was further ana-
lyzed by superposing the structural elements of the protein.
For this, the different chains of both the apo RappLS20 and
RappLS20 peptide-bound structures were superposed (Sup-
plementary Tables S3 and S4). To get insight into the struc-
tural changes induced in RappLS20 due to peptide bind-
ing, we calculated the average distance existing between the
main chain atoms of the apo- RappLS20 structure to the
equivalent main chain atoms of the superposed Phr*pLS20–
RappLS20 structure, and expressed these as RMSDs. The su-
perposition of all possible residues showed that the overall
structure did not change much, evidenced by the fact that
the RMSDs ranged from 1.33 to 3.54 Å (Supplementary Ta-
ble S3). However, visual inspection of these superpositions
suggested that the orientation of the NTDs changed rela-
tive to the CTDs. We therefore superposed only the CTDs
of the apo and peptide-bound monomers (RMSDs of 0.58–
2.86 Å) and the NTDs of all monomers (RMSDs of 0.64–
1.50 Å) (see Supplementary Table S3). In addition, we cal-
culated the RMSDs of the NTDs after superposition of the
CTDs, which were in the range of 1.30 to 7.0 Å (Supplemen-
tary Table S4). The significant increase in the RMSDs of the
NTDs after superposition of the CTDs compared to those
of the superposition of the NTDs confirmed the change in
relative orientation of the domains. We found that in the
presence of the peptide, the NTDs move in a single direc-
tion and have a tendency to swing outward, away from the
solenoid axis of the TPR. This movement can be observed
to various degrees and was most pronounced for two of the
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four monomers (chains C and G) in the Phr*pLS20–RappLS20
structure, which each belong to the two different respective
dimers.
To delineate further which regions were relatively rigid
or flexible, superpositions of subsets of the helices of the
CTDs were performed and inspected visually. These anal-
yses showed that the C-terminal helices H13–H17 were
invariant when compared to the preceding structural ele-
ments, as evidenced by RMSDs of 0.380–0.740 Å after the
superposition of helices H13-H17 (residues 268–361) of all
monomers of the apo and peptide-bound structures (Sup-
plementary Table S3). The superposition revealed that he-
lices H6 and H7 (residues 129–166) of the TPR domain
move inwards towards the center of the solenoid where the
peptide binds, and upwards towards the C-terminus. The
extent of this movement is distinct for the four chains of
the Phr*pLS20-bound RappLS20 and ranges from 2.1 to 3.5
Å. This ample range of movement confirms that the TPR
domain retains a high level of flexibility in the presence of
the bound peptide. The movements in helices H6 and H7
are related to an outward movement of the N-terminal 3-
helix bundle. In fact, the extent of both movements is cor-
related: the N-terminal bundles swing out over a larger dis-
tance when the TPR rearrangement is more pronounced.
The correlation between the displacement of helices H6 and
H7 and the tendency of the NTDs to move outward is likely
functionally important for the response of Rap to the pep-
tide. Figure 3A shows the positions of the effector domain
with respect to the TPR domain for one monomer of the
apo structure (chain B) and one monomer of the peptide-
bound structure (chain G).
Effect of Phr*pLS20 on RappLS20 oligomerization in solution
To investigate possible effects of peptide binding on the
oligomerization state of RappLS20 in solution, we performed
SV and SE ultracentrifugation experiments of RappLS20 in
the presence of synthetic Phr*pLS20. Interestingly, the pres-
ence of Phr*pLS20 induced a change in oligomerization state
of RappLS20 in a dose-dependent manner, resulting in the
formation of RappLS20 tetramers. At a 1:1 stoichiometry,
there was still a small trace of RappLS20 dimers, which was
no longer observed when the peptide was present in excess
with a 3:1 stoichiometry. Thus, an equilibrium between the
dimer and tetramer was observed, as was the case for apo
RappLS20. In fact, in the absence of the peptide, a small but
measurable concentration-dependent presence of tetramers
was observed in SV experiments of apo RappLS20, which in-
creased from 1.1% at 4.5 M (0.20 mg/ml) to 3.6% at 25
M (1.1 mg/ml).
SV assays showed a shift of the sedimentation coefficient
of RappLS20 from 4.9 S, corresponding to the protein dimer,
to an s-value of 7.1 S, compatible with a slightly elongated
shape of the RappLS20 tetramer (f/f0 = 1.44) (Figure 2C). To
confirm the oligomerization state of RappLS20 in the pres-
ence of the peptide, regardless of the hydrodynamic shape,
we carried out a SE experiment of RappLS20 at different con-
centrations (0–15 M or 0–0.67 mg/ml) in the presence of a
1:3 stoichiometry (RappLS20:Phr*pLS20). SE showed a buoy-
ant mass of 44 300 Da, corresponding to a molar mass of
174 000 ± 740 Da, in good agreement with the expected
Mw for the protein tetramer (Figure 2D). Together, these
data show that RappLS20 forms tetramers in solution in the
presence of Phr*pLS20.
The tetramerization interface of RappLS20
We next checked if tetramerization of RappLS20 observed by
AUC is also reflected in the crystal structures. When analyz-
ing the intermolecular contacts in the peptide-bound crys-
tal structure, we found an additional interface that explains
the tetrameric configuration of RappLS20, which surprisingly
was also found in the structure of the apo form. This second
interface formed through interactions between the helices
3 of the NTDs of the interacting molecules, and by inser-
tion of the N-terminus of helix H4 between helices H4-6
and the N-terminus of helix H3 of the opposite molecule.
We will refer to this interaction as the foot-2-foot interac-
tion (Figure 3B and C). Of the many interactions found
in the interface, we highlight here M79 and L80 located in
H4 (Figure 3D), which forms part of the CTD and interact
substantially with residues in the H4–H5 loop of the op-
posing monomer. Within the PSI-BLAST (47) set of pro-
teins, which includes RappLS20-like proteins, we found that
L80 is highly conserved (I, L or V in homologous proteins)
and sits in a hydrophobic pocket lined with residues F91,
Y92, L121, P125, I127, K131 of a chain from the oppo-
site dimer. Of these interacting residues, F91-Y92 are 100%
identical among the BLAST sequences, and 121 is mainly L
with a smaller percentage of I. In addition, P125 and I127
are very well conserved (mainly P, then A/E/D/T for P125
and 100% for I127). K131 is Q in most sequences, followed
by K, then smaller populations of Y, H, R. Interestingly,
within the 11 Rap proteins of B. subtilis, the conservation of
the residues forming this pocket is much smaller. Except for
F91-Y92 and L121, the remaining pocket residues and L80
and the preceding loop, containing M79, are poorly con-
served. This may indicate that peptide-induced tetrameriza-
tion is common among RappLS20-like proteins, but does not
occur among the genomic B. subtilis Rap proteins charac-
terized so far.
Table 2 gives the interface strengths for the tetramer in-
terfaces in the apo structure (one crystallographically in-
dependent interface) and the peptide-bound structure (two
crystallographically independent interfaces). The strength
of the interface area of the foot-2-foot interactions shows
that the N-terminal interactions are viable interactions that
are stronger than other contacts in the crystal lattice.
SAXS analysis of the particle size of RappLS20 and RcopLS20,
with and without Phr*pLS20
We have established the formation of RappLS20 tetramers us-
ing AUC and we have derived a possible interface of this in-
teraction from the crystal structures. The contacts observed
in the crystal surface could be crystallographic artefacts,
though, that may not occur in solution. Therefore, this in-
terface required confirmation, using different techniques to
provide additional insights into the oligomerization behav-
ior and shape of RappLS20 in solution in the presence and ab-
sence of the Phr*pLS20 peptide. Multiple size exclusion chro-
matography (SEC) and SAXS analyses were performed on
(combinations of) RappLS20, RcopLS20 and Phr*pLS20.
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Figure 3. RappLS20 tetramerization. (A) Cartoon representation of the superposition of the C-terminal domains of one of the peptide-bound chains (cyan)
on one of the apo chains (gray), highlighting The shift in the N-terminal domain (NTD). The peptide carbon atoms are shown in orange. (B) Side view
of the peptide-bound tetramer. The red arrows indicate the loops connecting helices H4 and H5. (C) Zoom of the area around the N-terminus of helix
H4, showing the insertion of this helix into the opposite monomer. (D) Close up view of the hydrophobic pocket of M79 and L80 in the formation of the
tetramer.
We analyzed apo RappLS20 at concentrations of 11 M to
0.11 mM (0.5–5 mg/ml) and RcopLS20 at concentrations of
70.9–709 M (1.44–14.4 mg/ml), both in the absence and
presence of Phr*pLS20 at a 5× molar excess. A summary of
the most important global SAXS parameters is given in Ta-
ble 3.
Comparison of SAXS data obtained for RappLS20 showed
that the presence of Phr*pLS20 provoked an increase in the
volume and weight of RappLS20 particles (Table 3). The pres-
ence of the peptide resulted in the following specific in-
creases: the radius of gyration increased from 3.8 to 4.5
nm; the Porod volume increased from 195 to 231 nm3; and
the maximum distance derived from the P(r) changed from
14.6 to 14.8 nm. These data are consistent with a tetrameric
RappLS20/Phr*pLS20 oligomerization as observed by AUC
data and the X-ray structures.
The size indicators obtained for RcopLS20 at a concentra-
tion of approximately 1.44 mg/ml (70.9 M), were similar
to those obtained for RappLS20 (Table 3). This indicates that
RcopLS20 (theoretical Mw of 20.3 kDa) has a similar effec-
tive size as RappLS20 (theoretical Mw = 44.4 kDa) in solu-
tion, consistent with AUC data published previously show-
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Table 3. SAXS data obtained for samples of RappLS20, RcopLS20, or mixed samples in the absence and presence of Phr*pLS20. The average value ob-
tained from curves at different concentrations are given, the values in brackets correspond to the highest and lowest values determined for the different
concentrations
Sample Phr*LS20 Rg (nm) Vporod (nm3) Rmax (nm)
RappLS20 − 3.8 (3.44–4.03) 195 (162–217.5) 14.6 (14.3–14.9)
+ 4.5 (4.21–4.52) 231 (174.1–263.5) 14.8 (14.0–16.0)
RcopLS20 − (4.52–6.19) (206–443) (15.8–21.7)
RappLS20/RcopLS20 − (5.3–11.9) (294–1281) (18.5–60.4)
+ (4.35–4.86) (255–286) (15.0–17.0)
ing that RcopLS20 is a tetramer in solution (23), and the AUC
presented herein showing that RappLS20 behaves as a dimer.
At higher concentrations, however, the parameters indicate
that the effective size of the particles increase, suggesting
that RcopLS20 forms complexes of higher Mw at increasing
concentrations.
SEC and SAXS analysis show that the RappLS20-RcopLS20
complex is disrupted by Phr*pLS20
Since we were also interested in studying the interaction be-
tween RappLS20 and RcopLS20 and the effect of the signaling
peptide on this possible interaction, we measured scatter-
ing curves of mixtures of RappLS20 and RcopLS20 at different
stoichiometries and concentrations, in the absence and pres-
ence of Phr*pLS20 (Table 3). In the absence of signaling pep-
tide, mixtures of RappLS20 and RcopLS20 exhibited a several-
fold increase in all particle size indicators, independent of
their relative stoichiometries. This shows that a complex be-
tween RappLS20 and RcopLS20 is indeed formed, confirming
direct interaction between these proteins. When mixtures of
RappLS20, RcopLS20 and Phr*pLS20 were analyzed by SAXS,
the overall indicators of particles size and shape (Table 3)
were similar to those of the RcopLS20 protein alone and the
RappLS20/Phr*pLS20 complex, regardless of the relative con-
centrations of the components.
Next, we analyzed the oligomerization behavior of
RappLS20 and RcopLS20 using analytical size exclusion chro-
matography (SEC) at a total protein concentration ranging
between 0.75 and 1.25 mg/ml and estimated the Mw of the
different complexes based on a calibration using proteins of
known Mw (Supplementary Table S5). The results show that
RappLS20 and RcopLS20 alone eluted at similar volumes, with
estimated weights of 101 and 94.4 kDa, respectively, corre-
sponding to RappLS20 dimers and RcopLS20 tetramers. The
formation of apo RappLS20 dimers in solution is in agree-
ment with AUC data reported above and with previously
reported SEC results (48). The tetrameric form of RcopLS20
is in agreement with AUC results reported before (23), but
does not agree with previously published SEC and sucrose
gradient results (48).
As mentioned above, higher order complexes were ob-
served by SAXS for mixtures of RappLS20 and RcopLS20
in absence of the signaling peptide. SEC experiments of
mixtures of RappLS20 and RcopLS20 showed similar results
(Supplementary Figure S2C–F). Addition of Phr*pLS20 to
the RappLS20 and RcopLS20 mixtures disrupted these higher
order complexes in SEC (Supplementary Figure S2H), in
agreement with SAXS results. Together, the SAXS and SEC
data are consistent with Phr*pLS20-dependent disruption of
RcopLS20–RappLS20 complexes and concomitant formation
of a RappLS20 tetramer.
SAXS confirms the formation of apo RappLS20 dimers and
RappLS20/Phr*pLS20 foot-2-foot tetramers in solution
In order to assess the agreement between X-ray struc-
ture and SAXS data, models of the monomer, dimer and
tetramer from the crystal structures were used to calculate
a fit with the SAXS scattering curves (Supplementary Ta-
ble S6). Based on the crystal lattices, two different tetramer
models were generated: one representing a foot-to-foot in-
duced tetramer, and the second generated using (weaker)
side-to-side CTD interactions found in the crystal struc-
tures. SAXS data of RappLS20 showed that at all tested
concentrations, the best model to explain the curves was
always a combination of dimer (Figure 1C) and foot-2-
foot tetramer (Figure 3B). Unacceptable fits were invariably
obtained for combinations of the RappLS20 monomer, the
dimer and for the CTD-based, side-to-side tetramer (Sup-
plementary Figure S3 and Supplementary Table S4). The
best fit for the apo RappLS20 SAXS curve at 0.5 mg/ml (11.3
M) was obtained with a dimer:tetramer ratio of 0.78:0.22.
The percentage of foot-2-foot tetramers increased at higher
RappLS20 concentrations; e.g. at 5 mg/ml (0.11 mM) the
RappLS20 dimer:tetramer ratio was 0.48:0.52 (Figure 4 and
Supplementary Table S6). Thus foot-2-foot tetramers are
found to coexist with dimers in solutions of apo RappLS20,
and their proportion depended on the RappLS20 concentra-
tion.
Importantly, the presence of Phr*pLS20 caused a consid-
erable increase in the percentage of RappLS20 tetramers,
which was particularly noticeable at low concentrations of
RappLS20 (Figure 4). For example, at 0.5 mg/ml (11.3 M)
the presence of the signaling peptide caused the percentage
of tetramers to increase from 22 to 75%. It is also worth not-
ing that, as was the case for apo RappLS20, the proportion
of tetramers was augmented at increasing peptide-bound
RappLS20 concentrations (maintaining the stoichiometries
between RappLS20 and Phr*pLS20 constant). In fact, 100%
of RappLS20 was in tetramer form at RappLS20 concentra-
tions above 2.5 mg/ml (57.7 M). In summary, the SAXS
data and the results of the ultracentrifugation experiments
described above show that, in the absence of the peptide,
RappLS20 has a tendency to form foot-2-foot tetramers at
high concentrations. However, formation of these tetramers
is strongly enhanced by the presence of the signaling peptide
(Figure 4).
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Figure 4. SAXS determined concentration-dependent dimer:tetramer stoichiometry of the apo and peptide-bound form of RappLS20. The vertical bars
represent the proportion of dimers and foot-2-foot tetramers of RappLS20 and RappLS20/Phr*pLS20 samples at three different concentrations, as calculated
with OLIGOMER (32).
DISCUSSION
Oligomerization state of RappLS20
In a previous study, we demonstrated that RappLS20 acti-
vates expression of conjugation genes by relieving RcopLS20-
mediated repression of the main conjugation promoter Pc,
and that this anti-repression activity of RappLS20 is in-
hibited by Phr*pLS20 (22). The results of the different ex-
perimental approaches applied in these studies show that
RappLS20 forms dimers which have an intrinsic ability to
produce tetramers, but that tetramer formation is partic-
ularly stimulated by the cognate mature signaling peptide
Phr*pLS20. These results strongly suggest that tetrameriza-
tion is a crucial feature for inactivation of RappLS20. In
the crystal structure, we observed two possible modes by
which RappLS20 may tetramerize. The solution experiments
allowed the identification of the functional configuration of
the RappLS20 tetramerization, which we named the foot-2-
foot interaction. Interestingly, in this complex, the dimer-
dimer interface involves mainly interactions between the
NTDs. This proposed model of the tetramer is also com-
patible with AUC data, since the frictional ratio indicates a
slightly elongated model for the dimer and an even more
elongated model for the tetramer. The deviations in the
Mw estimations from SEC data may indicate non-globular
molecular shapes and therefore also agree with the dimer
and foot-2-foot models proposed by us.
The foot-2-foot interfaces seem to be stronger in the
apo crystal structure compared to the peptide-bound struc-
ture (see Table 2). There are several possible explanations
for this observation. First, the resolution of the apo struc-
ture is higher and the electron density of the loop region
is clearer, allowing a better positioning of the interact-
ing residues. Second, the lower resolution of the peptide-
bound structure may obscure bridging water molecules
and ions, which would increase the strength of the inter-
action surface. And third, crystal contacts may push the
NTDs to a non-preferred orientation in the apo struc-
ture that favors tetramer formation. However, our com-
bined data based on results from different techniques pro-
vide compelling evidence that Phr*pLS20 binding enhances
RappLS20 homotetramerization via a foot-2-foot interac-
tion. Notably, AUC and SAXS experiments showed that
RappLS20 foot-2-foot tetramers can also form in solution in
the absence of the signaling peptide, and that the propor-
tion of the tetramers is concentration dependent. Our data
therefore suggest that RappLS20 dimers and tetramers are in
a concentration-dependent equilibrium that is shifted in fa-
vor of the tetramer upon peptide binding.
Interaction between RappLS20 and RcopLS20 in presence and
absence of Phr*pLS20
Our SAXS results firmly establish that RappLS20 and
RcopLS20 interact to form larger complexes, as indicated
by the increase in particle size in solution. Interest-
ingly, RappLS20/RcopLS20 mixtures additionally containing
Phr*pLS20 yielded particle size parameters in the same range
as those obtained for the RappLS20/Phr*pLS20 complex and
RcopLS20 alone, indicating that Phr*pLS20 interferes with in-
teractions between RappLS20 and RcopLS20. These data were
corroborated by SEC, and overall show that Phr*pLS20 re-
stores the repressive action of RcopLS20 (22,23) by modulat-
ing the direct interaction between RappLS20 and RcopLS20.
By extrapolating the fact that the NTD of RRNPP pro-
teins determines their functionality, RappLS20 and RcopLS20
interact most likely through the NTD of RappLS20. There
is a similarity to the RapF/ComA system, in that ComA
and RcopLS20 are both DNA binding proteins that harbor
an HTH domain. RapF binds ComA through a surface
that mimics the surface of DNA (16). This interaction is
mediated partly through a 27-residue linker that connects
the NTD to the CTD (16). However, the corresponding
linker in RappLS20 is 14 residues shorter, and the electro-
static surface of RappLS20 does not show pronounced neg-
ative charges. These observations indicate that the NTD
of RappLS20 does not likely mimic DNA, suggesting that
RappLS20 binds to its modulator protein RcopLS20 in a very
different way. A possible implication of this is that RappLS20
may not interact with the RcopLS20 N-terminal DNA-
binding domain, but rather with its CTD, which resembles
the lambda-phage C1 repressor (Interpro IPR010982 fam-
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ily). Future structural studies will be performed to deter-
mine how RcopLS20 interacts with RappLS20.
Complex formation of RRNPP proteins compared with
RappLS20
Dimerization like that observed here in RappLS20 has been
observed in the apo form of RRNPP proteins that bind
DNA such as PlcR and PrgX, but is uncommon for other
Rap proteins. Most Rap proteins have been reported to be
monomers in solution, including RapF, RapH and RapK
(16), and RapJ (17). RapH, however, does form dimers (18).
For RapF (16) and RapJ (17), large conformational changes
in the N-terminus have been observed in peptide binding,
but no related changes in oligomerization state have been
reported. In these Rap proteins, a large internal conforma-
tional change was proposed to account for the functional ef-
fects of peptide binding. In contrast, a change in oligomer-
ization state was found for PlcR (4) and PrgX (49,50) upon
peptide binding. The effect of peptide binding was, how-
ever, distinct for the two proteins: PlcR tetramerized upon
peptide binding, whereas the two different peptides that
compete for PrgX binding have stabilizing and destabiliz-
ing effects on tetramerization, respectively. Interestingly, the
SAXS results of PlcR showed an extended volume, indi-
cating formation of higher order oligomerization. At low
protein concentrations, these volumes resemble to a great
extent the foot-2-foot tetramers presented herein and were
interpreted as tetramers, albeit through interactions in the
N-terminal part of the TPR domain (4).
In RappLS20, binding of the peptide results in changes
of several alpha helices of the TPR domain, which in turn
translates into changes in orientation of the NTDs such
that they allow foot-2-foot interactions between opposing
NTDs. In the peptide-bound structure, two crystallograph-
ically independent tetramer configurations were found,
which are formed through foot-2-foot interactions between
two symmetry-related dimers. In each of the tetramers, one
of the NTDs moves outwards, thereby modifying the inter-
action interface. In the tetramer formed by chains G and E
and their symmetry-related counterparts, the displacement
of the NTD of chain G is most pronounced. In the tetramer
formed by chains A and C and their symmetry-related coun-
terparts, displacement of the NTD of chain C is most pro-
nounced, but this displacement is smaller than that of chain
G. The combined effect in the G/E tetramer is a stronger in-
teraction than that observed for the A/C tetramer, judged
by the strength of the buried surface area (Table 2). Curi-
ously, the strength of the dimer interface in both peptide-
bound tetramers is slightly decreased, suggesting that pep-
tide weakens the dimer interface (Table 2).
The movement of the NTD with respect to its CTD ob-
served here for Rap pLS20 upon Phr*pLS20 peptide binding
has also been observed for other members of the Rap fam-
ily, such as RapF (PDB code 4i9c), RapJ (4gyo) and NprR
(5dbk). Intriguingly, the movement of the NTD of RapLS20
is opposite to that observed in these other structures. In
fact, RapJ (17) and RapF (11) contract upon peptide bind-
ing, causing the N-terminal bundle to merge with the TPR
domain. The position of the NTDs in these structures is
not compatible with the tetrameric structures observed for
RappLS20. The fact that a tetrameric oligomerization state
is not observed for RapJ and RapF is consistent with this
observation.
Tetramers of RRNPP proteins have been observed us-
ing a range of techniques, but atomic models of tetramers
have been proposed only for NprR and PrgX. In PrgX,
tetramerization has been proposed to occur through the
CTDs of the apo protein (51). PrgX tetramers are desta-
bilized upon binding of the cognate cCF10 peptide, so
this mechanism is very distinct from the mechanism pro-
posed here for RappLS20. For NprR, however, the NTDs are
important for the formation of tetramers, and the dimer-
to-tetramer transition is induced by the peptide (46). The
peptide-dependent transformation from dimer to tetramer
of NprR is reminiscent of the behavior of RappLS20. The in-
teractions in the NprR tetramer occur between the TPR and
NTD domains, though foot-2-foot interactions like those
observed for RappLS20 were not found for the peptide-bound
structure of NprR. Instead, the dimers are rotated 90◦ with
respect to each other, and the NTDs bind on the sides of
the TPR domains. Interestingly, the NTDs in the peptide-
bound NprR structure move inward as is the case for the
monomeric RapF and RapJ; however, this does not lead to
tetramers for these Rap proteins.
The foot-2-foot tetramerization observed exclusively for
RappLS20 may be the consequence of the very different NTD
of this protein. Interestingly, interactions between the he-
lices immediately following the NTDs are a common theme
between the tetramerization interactions of RappLS20 and
of the other types of interactions described above for other
members of the RRNPP family, suggesting that this part of
the TPR domain is of direct importance in translating pep-
tide binding into a functional effect.
Implications of the mechanism of RappLS20
The homotetramerization caused by the foot-2-foot inter-
actions of the NTDs of RappLS20 provides an explanation
for the activation of the RcopLS20 partner (Figure 3). In the
absence of Phr*pLS20, the NTDs are positioned such that
they allow the interaction with RcopLS20. However, upon
binding the signaling peptide, the NTDs shift outwards, fa-
cilitating the formation of the homotetramer, leading to a
change of the interaction surface of the NTDs that is no
longer available for interactions with RcopLS20. This change
leads to a release and subsequent reactivation of RcopLS20,
which is again able to bind to the Pc (22). Thus, the struc-
tural changes introduced in the RappLS20 structure deter-
mine whether the conjugation process will be activated or
not.
In summary, our approach combining four different tech-
niques has been crucial in the elucidation of the oligomer-
ization behavior of RappLS20 and its interaction part-
ners. We have determined the X-ray structures of apo
RappLS20 and the Phr*pLS20-bound structure. These struc-
tures demonstrated that binding of the peptide changes the
position of the NTDs with respect to the CTDs and re-
sult in a transition of homodimers to homotetramers of
RappLS20, through a foot-2-foot interaction between the
repositioned NTDs. SAXS, SEC and AUC experiments
confirm this model, which differs substantially from the
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model proposed for other RRNPP family members. The
differences in peptide-dependent oligomerization behavior
seem to be closely related to the function of the NTDs of
Rap proteins. Thus, the main (and possibly only) function
of the C-terminal TPR domain seems to be in binding the
peptide, whereas the NTD is responsible for exerting the bi-
ological function of the protein in response to binding of
the cognate peptide.
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